A phase I study afatinib/carboplatin/paclitaxel induction chemotherapy followed by standard chemoradiation in HPV-negative or high-risk HPV-positive locally advanced stage III/IVa/IVb head and neck squamous cell carcinoma

Abstract B268: A Phase I Study of CUDC-101, a multitarget inhibitor of HDACs, EGFR, and HER2, in combination with chemoradiation in patients with intermediate/high risk locally advanced squamous cell carcinoma of the head and neck.

10.1158/1535-7163.targ-13-b268 ◽

2013 ◽

Cited By ~ 1

Author(s):

Antonio Jimeno ◽

Thomas Galloway ◽

Lori Wirth ◽

Jill Gilbert ◽

Nabil Saba ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

High Risk ◽

Phase I ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Phase I Study ◽

Locally Advanced ◽

Phase I study of cabazitaxel-PF induction chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN).

10.1200/jco.2014.32.15_suppl.e17009 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. e17009-e17009

Author(s):

Nadia Camille ◽

Rita Babu ◽

Richard Lorne Bakst ◽

Vishal Gupta ◽

Brett Miles ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Phase I ◽

Cell Carcinoma ◽

Head And Neck ◽

Induction Chemotherapy ◽

Squamous Cell ◽

Phase I Study ◽

Locally Advanced ◽

Phase I study of cabazitaxel-PF induction chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN).

10.1200/jco.2015.33.15_suppl.e17082 ◽

2015 ◽

Vol 33 (15_suppl) ◽

pp. e17082-e17082 ◽

Cited By ~ 1

Author(s):

Adnan Khan ◽

Rita Babu ◽

Amiya Vaz ◽

Michele Deyne-Borza ◽

Alicia Price ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Phase I ◽

Cell Carcinoma ◽

Head And Neck ◽

Induction Chemotherapy ◽

Squamous Cell ◽

Phase I Study ◽

Locally Advanced ◽

ORCA-2: A phase I study of olaparib in addition to cisplatin-based concurrent chemoradiotherapy for patients with high risk locally advanced squamous cell carcinoma of the head and neck.

10.1200/jco.2016.34.15_suppl.tps6108 ◽

2016 ◽

Vol 34 (15_suppl) ◽

pp. TPS6108-TPS6108 ◽

Cited By ~ 1

Author(s):

Martin David Forster ◽

Ruheena Mendes ◽

Kevin J. Harrington ◽

Teresa Guerrero Urbano ◽

Helen Baines ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

High Risk ◽

Phase I ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Phase I Study ◽

Locally Advanced ◽

866P ORCA-2: A phase I study of olaparib in addition to cisplatin-based concurrent chemoradiotherapy for patients with high risk locally advanced (LA) squamous cell carcinoma of the head and neck (HNSCC)

Annals of Oncology ◽

10.1016/j.annonc.2021.08.1276 ◽

2021 ◽

Vol 32 ◽

pp. S789-S790

Author(s):

M. Forster ◽

R. Mendes ◽

T. Guerrero Urbano ◽

M. Evans ◽

M. Lei ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

High Risk ◽

Phase I ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Phase I Study ◽

Locally Advanced

Induction Chemotherapy with Docetaxel, Cisplatin and Capecitabine, Followed by Combined Cetuximab and Radiotherapy in Patients with Locally Advanced Inoperable Squamous Cell Carcinoma of the Head and Neck: A Phase I-II Study

Oncology ◽

10.1159/000347232 ◽

2013 ◽

Vol 84 (4) ◽

pp. 251-254 ◽

Cited By ~ 2

Author(s):

Francesco Perri ◽

Paolo Muto ◽

Angela Argenone ◽

Franco Ionna ◽

Francesco Longo ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Phase I ◽

Cell Carcinoma ◽

Head And Neck ◽

Induction Chemotherapy ◽

Squamous Cell ◽

Locally Advanced

8511 POSTER DISCUSSION Phase I Trial of Albumin-bound Paclitaxel (A), Cisplatin (P) and 5-Fluorouracil (F) as Induction Chemotherapy (IC) Followed by Concurrent Chemoradiotherapy (CRT) With Carboplatin (Cb) in Patients (pts) With Locally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN)

European Journal of Cancer ◽

10.1016/s0959-8049(11)72153-0 ◽

2011 ◽

Vol 47 ◽

pp. S547

Author(s):

I. Diaz-Pad ilia ◽

J. Waldron ◽

A. Hope ◽

E.X. Chen ◽

K. Chan ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Phase I ◽

Cell Carcinoma ◽

Head And Neck ◽

Induction Chemotherapy ◽

Squamous Cell ◽

Phase I Trial ◽

Locally Advanced ◽

Phase I study of concurrent chemoradiotherapy (CRT) with S-1 and cisplatin (CDDP) in patients (pts) with unresectable locally advanced squamous cell carcinoma of head and neck (SCCHN)

10.1200/jco.2005.23.16_suppl.5575 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 5575-5575 ◽

Cited By ~ 2

Author(s):

M. Tahara ◽

H. Minami ◽

H. Mukai ◽

K. Kawada ◽

M. Kawashima ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Phase I ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Phase I Study ◽

Locally Advanced ◽

A phase I study of metformin in combination with cisplatin and radiation in locally advanced head and neck squamous cell carcinoma.

10.1200/jco.2016.34.15_suppl.tps6109 ◽

2016 ◽

Vol 34 (15_suppl) ◽

pp. TPS6109-TPS6109

Author(s):

Trisha Michel Wise-Draper ◽

Vinita Takiar ◽

Michelle Lynn Mierzwa ◽

Bradley Joseph Huth ◽

Kevin P. Redmond ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Phase I ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Phase I Study ◽

Locally Advanced ◽

Neck Squamous Cell Carcinoma ◽

Advanced Head

Significance of mammalian target of rapamycin in patients with locally advanced stage IV head and neck squamous cell carcinoma receiving induction chemotherapy with docetaxel, cisplatin, and fluorouracil

Head & Neck ◽

10.1002/hed.24111 ◽

2015 ◽

Vol 38 (S1) ◽

pp. E844-E852 ◽

Cited By ~ 12

Author(s):

Shau-Hsuan Li ◽

Wei-Che Lin ◽

Tai-Lin Huang ◽

Chang-Han Chen ◽

Tai-Jan Chiu ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Induction Chemotherapy ◽

Squamous Cell ◽

Locally Advanced ◽

Mammalian Target Of Rapamycin ◽

Stage Iv ◽

Neck Squamous Cell Carcinoma ◽

Advanced Stage